About
alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundam
CEOJohn Maraganore
HQCambridge, Massachusetts
Employees2,246